Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Roaccutane

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Isotretinoin (13‐cis retinoic acid) is the most potent known inhibitor of sebum production. The multiple modes of action for… Expand
2008
2008
Background  Oral isotretinoin is currently the most effective therapy for acne, but is associated with numerous adverse effects… Expand
2000
2000
Introduction. Les recommandations de prescription et de delivrance du Roaccutane® (isotretinoine) ont ete renforcees en 1997… Expand
Review
1997
Review
1997
BACKGROUND Oral isotretinoin (Roaccutane) revolutionized the treatment of acne when it was introduced in 1982. METHODS Twelve… Expand
Highly Cited
1997
Highly Cited
1997
Acne vulgaris is a common inflammatory dermatosis capable of producing significant psychological and physical scarring. The… Expand
1997
1997
1 Lambert DC Dalar S. BOLT F et til Acute generalised toLis pustular Liermatitis induced by dilliazem. Br j DcnuaUil ISISS: 118… Expand
Review
1997
Review
1997
Oral and topical antibiotics play a major role in acne therapy. Physicians base treatment choices on personal perceptions of… Expand
Review
1989
Review
1989
Abnormal cutaneous photosensitivity is included among a number of more common side effects of tretinoin (Fig. 1; al l trans-ret… Expand
1989
1989
A patient with Darier's disease was discovered to have persistent, asymptomatic cervical and thoracic spinal hyperostoses after… Expand
Highly Cited
1985
Highly Cited
1985
Etretinate and isotretinoin were compared with respect to their clinical effects and changes in serum lipoprotein concentrations.